Carl LeBel, Chief Development Officer at Frequency Therapeutics, Inc. (FREQ), sold 2,043 shares at $3.53 ($8K) on 2022-02-22, disclosed to the SEC on 2022-02-23.
Open-market sale of $8k FREQ by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.87 | 974 | $4K | 50.0% |
| 2 | $3.53 | 1,069 | $4K | 50.0% |
| Total | $3.69 avg | 2,043 | $8K | 100% |
| Filing → |
| FREQ | SELL | 2022-02-16 | $4K | — | Filing → |
| OTIC | SELL | 2016-11-22 | $384K | — | Filing → |
| OTIC | SELL | 2016-09-08 | $381K | — | Filing → |